TapewireFind a company

person · Reporting owner

YOUNG PHILIP M

Disclosed activity across 4 companies

Tapewire entity
36490
SEC CIK
0001048637

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CARLSMED, INC.CARL · Entity 5551DirectorJune 03, 2026June 22, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CARLSMED, INC.

Report date June 03, 2026 · Filed June 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect31,031 Reported balance After 2026-06-03 transaction · row 1
1 source row

Row 1 · 2026-06-03 · Grant · Acquired 13,698 · Balance 31,031

F1: Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

Common StockSEC Table I · non-derivativeIndirectSee footnotes35,566 Reported balance Holding disclosure · report date 2026-06-03 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 35,566

F2: Stock held by PMY Partners LP.

F3: Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.

Common StockSEC Table I · non-derivativeIndirectSee footnotes53,333 Reported balance Holding disclosure · report date 2026-06-03 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 53,333

F4: Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees.

F5: Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.

Filing footnotes · ownership attribution and instrument terms

F1: Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

F2: Stock held by PMY Partners LP.

F3: Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.

F4: Includes shares of the Issuer's common stock held by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees.

F5: Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Section 16 reporting ended · disclosed 2017-06-08. Current position is not established by this disclosure.

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectDirectly owned by USVP IX0 Last balance in matching sequence After 2017-06-02 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2017-06-02 · Conversion · Acquired 8,000,000 · Balance 8,000,000

F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Row 2 · 2017-06-02 · Other · Disposed 8,000,000 · Balance 0

F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F2: Prorata distribution in kind from the partnership without consideration to its limited partners.

F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Class B Common StockSEC Table II · derivative / convertible securityIndirectDirectly owned by USVP IX3,713,775 Reported balance After 2017-06-02 transaction · row 3 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 3 · 2017-06-02 · Conversion · Disposed 8,000,000 · Balance 3,713,775

F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F2: Prorata distribution in kind from the partnership without consideration to its limited partners.

F3: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Section 16 reporting ended · disclosed 2018-11-13. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Stock, $0.001 per shareSEC Table I · non-derivativeIndirectDirectly owned by USVP IX0 Reported balance After 2018-11-08 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2018-11-08 · Other · Disposed 4,280,779 · Balance 0

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common Stock, $0.001 per shareSEC Table I · non-derivativeDirect856,155 Reported balance After 2018-11-08 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2018-11-08 · Other · Acquired 856,155 · Balance 856,155

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Common Stock, $0.001 per shareSEC Table I · non-derivativeDirect0 Reported balance After 2018-11-08 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2018-11-08 · Other · Disposed 856,155 · Balance 0

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Common Stock, $0.001 per shareSEC Table I · non-derivativeIndirectDirectly owned by Steven Krausz97,593 Last balance in matching sequence After 2018-11-13 transaction · row 6 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 4 · 2018-11-08 · Other · Acquired 102,093 · Balance 102,093

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Row 5 · 2018-11-12 · Sale · Disposed 2,100 · Balance 99,993

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.95 to $.96, inclusive for sales made on November 12, 2018. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Row 6 · 2018-11-13 · Sale · Disposed 2,400 · Balance 97,593

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common Stock, $0.001 per shareSEC Table I · non-derivativeIndirectDirectly owned by David Liddle69,609 Reported balance After 2018-11-08 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 7 · 2018-11-08 · Other · Acquired 69,609 · Balance 69,609

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common Stock, $0.001 per shareSEC Table I · non-derivativeIndirectDirectly owned by Paul Matteucci60,408 Reported balance After 2018-11-08 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 8 · 2018-11-08 · Other · Acquired 60,408 · Balance 60,408

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common Stock, $0.001 per shareSEC Table I · non-derivativeIndirectDirectly owned by Jonathan Root85,851 Reported balance After 2018-11-08 transaction · row 9 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 9 · 2018-11-08 · Other · Acquired 85,851 · Balance 85,851

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common Stock, $0.001 per shareSEC Table I · non-derivativeIndirectDirectly owned by Casey Tansey60,336 Reported balance After 2018-11-08 transaction · row 10 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 10 · 2018-11-08 · Other · Acquired 60,336 · Balance 60,336

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common Stock, $0.001 per shareSEC Table I · non-derivativeIndirectDirectly owned by Philip Young82,370 Reported balance After 2018-11-08 transaction · row 11 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 11 · 2018-11-08 · Other · Acquired 82,370 · Balance 82,370

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.95 to $.96, inclusive for sales made on November 12, 2018. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Section 16 reporting ended · disclosed 2018-11-14. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectDirectly owned by USVP IX1,084,127 Reported balance After 2018-11-08 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2018-11-08 · Other · Disposed 1,084,127 · Balance 1,084,127

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common StockSEC Table I · non-derivativeDirect216,825 Reported balance After 2018-11-08 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2018-11-08 · Other · Acquired 216,825 · Balance 216,825

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2018-11-08 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2018-11-08 · Other · Disposed 216,825 · Balance 0

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Common StockSEC Table I · non-derivativeIndirectDirectly owned by Irwin Federman18,212 Reported balance After 2018-11-08 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 4 · 2018-11-08 · Other · Acquired 18,212 · Balance 18,212

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectDirectly owned by Steven Krausz22,573 Reported balance After 2018-11-08 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 5 · 2018-11-08 · Other · Acquired 22,573 · Balance 22,573

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectDirectly owned by David Liddle15,391 Reported balance After 2018-11-08 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 6 · 2018-11-08 · Other · Acquired 15,391 · Balance 15,391

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectDirectly owned by Paul Matteucci13,356 Reported balance After 2018-11-08 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 7 · 2018-11-08 · Other · Acquired 13,356 · Balance 13,356

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectDirectly owned by Jonathan Root18,982 Reported balance After 2018-11-08 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 8 · 2018-11-08 · Other · Acquired 18,982 · Balance 18,982

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Common StockSEC Table I · non-derivativeIndirectDirectly owned by Philip Young18,212 Reported balance After 2018-11-08 transaction · row 9 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 9 · 2018-11-08 · Other · Acquired 18,212 · Balance 18,212

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 03, 2026 Filed Jun 22, 2026 10:01 UTC CARLSMED, INC. CARL · Entity 5551 GrantCommon Stock 13,698 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-276599 · ownership.xml · nonDerivative · entry 1

YOUNG PHILIP M · CIK 0001048637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,031

F1 · shares: Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

Read SEC document
July 24, 2025 Filed Jul 25, 2025 00:25 UTC CARLSMED, INC. CARL · Entity 5551 ConversionSeries B Preferred Stock · Derivative 28,900 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-098528 · ownership.xml · derivative · entry 5

YOUNG PHILIP M · CIK 0001048637 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 28,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

F3 · price: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

F3 · derivative.exercise_date: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

F3 · derivative.expiration_date: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

F4 · ownership.nature: Stock held by PMY Partners LP.

F5 · ownership.nature: Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.

Read SEC document
July 24, 2025 Filed Jul 25, 2025 00:25 UTC CARLSMED, INC. CARL · Entity 5551 PurchaseCommon Stock 53,333 $15.00 $799,995.00
Disclosure

SEC source: 0000950170-25-098528 · ownership.xml · nonDerivative · entry 4

YOUNG PHILIP M · CIK 0001048637 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 53,333

F8 · shares: Includes 53,333 shares of the Issuer's common stock purchased by the Young Family Trust dtd 04/13/1998 Nancy Halsey Young & Philip Young, Trustees (the "Trust") in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.

F9 · ownership.nature: Stock held by the Trust.

F10 · ownership.nature: Reporting Person is a trustee of the Trust and has voting and dispositive power over the stock held by the Trust.

Read SEC document
July 24, 2025 Filed Jul 25, 2025 00:25 UTC CARLSMED, INC. CARL · Entity 5551 PurchaseCommon Stock 6,666 $15.00 $99,990.00
Disclosure

SEC source: 0000950170-25-098528 · ownership.xml · nonDerivative · entry 3

YOUNG PHILIP M · CIK 0001048637 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 35,566

F6 · shares: Includes 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share. The purchase was made directly from the underwriters in connection with the offering.

F7 · balance_after: (7) Includes (i) 6,666 shares of the Issuer's common stock purchased by PMY Partners L.P. in the Issuer's initial public offering at the public offering price of $15.00 per share, and (ii) 28,900 shares of common stock issued to PMY Partners L.P. upon the conversion of outstanding preferred stock on a 1-to-1 basis, immediately prior to the closing of the Issuer's public offering.

F4 · ownership.nature: Stock held by PMY Partners LP.

F5 · ownership.nature: Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.

Read SEC document
July 24, 2025 Filed Jul 25, 2025 00:25 UTC CARLSMED, INC. CARL · Entity 5551 ConversionCommon Stock 28,900 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-25-098528 · ownership.xml · nonDerivative · entry 2

YOUNG PHILIP M · CIK 0001048637 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 28,900

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.

F4 · ownership.nature: Stock held by PMY Partners LP.

F5 · ownership.nature: Reporting Person is the sole general partner of PMY Partners L.P. and has voting and dispositive power over the stock held by PMY Partners L.P.

Read SEC document
July 22, 2025 Filed Jul 25, 2025 00:25 UTC CARLSMED, INC. CARL · Entity 5551 GrantCommon Stock 17,333 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-098528 · ownership.xml · nonDerivative · entry 1

YOUNG PHILIP M · CIK 0001048637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,333

F1 · shares: Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years.

F2 · shares: Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock.

F1 · balance_after: Constitute an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in equal annual installments over three years.

F2 · balance_after: Includes 17,333 unvested restricted stock units convertible into approximately 17,333 shares of the Issuer's common stock.

Read SEC document
November 13, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 SaleCommon Stock, $0.001 per share 2,400 $0.95 $2,280.00
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 6

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Steven Krausz

Disclosed balance after: 97,593

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 12, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 SaleCommon Stock, $0.001 per share 2,100 $0.96 $2,006.76
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 5

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Steven Krausz

Disclosed balance after: 99,993

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.95 to $.96, inclusive for sales made on November 12, 2018. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 18,212 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 9

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Philip Young

Disclosed balance after: 18,212

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 18,982 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 8

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Jonathan Root

Disclosed balance after: 18,982

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 13,356 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 7

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Paul Matteucci

Disclosed balance after: 13,356

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 15,391 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 6

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by David Liddle

Disclosed balance after: 15,391

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 22,573 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 5

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Steven Krausz

Disclosed balance after: 22,573

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 18,212 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 4

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Irwin Federman

Disclosed balance after: 18,212

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 216,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 3

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 216,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 2

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,825

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Read SEC document
November 08, 2018 Filed Nov 14, 2018 01:13 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 OtherCommon Stock 1,084,127 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000007 · edgar.xml · nonDerivative · entry 1

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 1,084,127

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.direct: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 82,370 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 11

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Philip Young

Disclosed balance after: 82,370

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 60,336 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 10

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Casey Tansey

Disclosed balance after: 60,336

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 85,851 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 9

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Jonathan Root

Disclosed balance after: 85,851

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 60,408 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 8

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Paul Matteucci

Disclosed balance after: 60,408

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 69,609 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 7

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by David Liddle

Disclosed balance after: 69,609

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 102,093 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 4

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by Steven Krausz

Disclosed balance after: 102,093

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 856,155 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 3

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 856,155 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 2

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 856,155

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

Read SEC document
November 08, 2018 Filed Nov 13, 2018 22:18 UTC INTERMOLECULAR INC IMI · Entity 154785 OtherCommon Stock, $0.001 per share 4,280,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-18-000004 · edgar.xml · nonDerivative · entry 1

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 0

F1 · kind: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F1 · price: Represents a pro-rata, in-kind distribution by U.S. Venture Partners IX, L.P. ("USVP IX"), without additional consideration, to its partners.

F2 · ownership.nature: This report is one of two reports each on a separate Form 4; however, these forms are related to the same transaction being filed by the reporting persons. The shares are held of record by USVP IX. Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Irwin Federman, a director of the Issuer, and each of Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, Casey Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionSeries F Convertible Preferred Stock · Derivative 3,795,620 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · derivative · entry 12

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 570,769 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionSeries E Convertible Preferred Stock · Derivative 948,855 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · derivative · entry 11

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 163,962 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F3 · derivative.exercise_date: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F3 · derivative.expiration_date: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionSeries D Convertible Preferred Stock · Derivative 1,397,478 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · derivative · entry 10

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 210,147 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionSeries C Convertible Preferred Stock · Derivative 3,142,670 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · derivative · entry 9

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 472,581 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionSeries B Convertible Preferred Stock · Derivative 2,102,315 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · derivative · entry 8

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 389,893 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F2 · derivative.exercise_date: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F2 · derivative.expiration_date: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionSeries A Convertible Preferred Stock · Derivative 2,400,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · derivative · entry 7

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 360,902 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.exercise_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F1 · derivative.expiration_date: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionCommon Stock 570,769 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 6

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,168,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionCommon Stock 163,962 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 5

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,597,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Shares of Series E Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1728 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionCommon Stock 210,147 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 4

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,433,523

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionCommon Stock 472,581 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 3

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,223,376

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionCommon Stock 389,893 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 2

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 750,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1855 conversion rate immediately prior to the closing of the Issuer's IPO for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Certificate of Incorporation). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
May 07, 2018 Filed May 10, 2018 01:19 UTC Inspire Medical Systems, Inc. INSP · Entity 1186 ConversionCommon Stock 360,902 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-18-031866 · a4.xml · nonDerivative · entry 1

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

KRAUSZ STEVEN M · CIK 0001190636 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 360,902

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A, Series C, Series D and Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering ("IPO") for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). These shares had no expiration date.

F4 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Casey Tansey, a director of the Issuer, and each of Irwin Federman, Steven M. Krausz, David E. Liddle, Paul A. Matteucci, Jonathan D. Root, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 18:35 UTC BOX INC BOX · Entity 3932 ConversionClass B Common Stock · Derivative 8,000,000 $0.00 $0.00
Disclosure

SEC source: 0001548538-17-000012 · edgar.xml · derivative · entry 3

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 3,713,775

Underlying: Class A Common Stock · 8,000,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · kind: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.underlying_shares: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 18:35 UTC BOX INC BOX · Entity 3932 OtherClass A Common Stock 8,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-17-000012 · edgar.xml · nonDerivative · entry 2

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 0

F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F2 · kind: Prorata distribution in kind from the partnership without consideration to its limited partners.

F2 · price: Prorata distribution in kind from the partnership without consideration to its limited partners.

F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
June 02, 2017 Filed Jun 5, 2017 18:35 UTC BOX INC BOX · Entity 3932 ConversionClass A Common Stock 8,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-17-000012 · edgar.xml · nonDerivative · entry 1

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 8,000,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · kind: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
June 02, 2017 Filed Jun 8, 2017 23:42 UTC Amendment BOX INC BOX · Entity 3932 ConversionClass B Common Stock · Derivative 8,000,000 $0.00 $0.00
Disclosure

SEC source: 0001548538-17-000015 · edgar.xml · derivative · entry 3

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 3,713,775

Underlying: Class A Common Stock · 8,000,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · kind: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · derivative.underlying_shares: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
June 02, 2017 Filed Jun 8, 2017 23:42 UTC Amendment BOX INC BOX · Entity 3932 OtherClass A Common Stock 8,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-17-000015 · edgar.xml · nonDerivative · entry 2

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 0

F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F2 · kind: Prorata distribution in kind from the partnership without consideration to its limited partners.

F2 · price: Prorata distribution in kind from the partnership without consideration to its limited partners.

F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document
June 02, 2017 Filed Jun 8, 2017 23:42 UTC Amendment BOX INC BOX · Entity 3932 ConversionClass A Common Stock 8,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001548538-17-000015 · edgar.xml · nonDerivative · entry 1

Presidio Management Group IX, L.L.C. · CIK 0001527715 · 10% owner

U S Venture Partners IX L P · CIK 0001309185 · 10% owner

FEDERMAN IRWIN · CIK 0001192391 · 10% owner

LIDDLE DAVID E · CIK 0001212726 · 10% owner

Matteucci Paul A · CIK 0001370817 · 10% owner

ROOT JONATHAN D · CIK 0001225480 · 10% owner

Tansey Casey M · CIK 0001474322 · 10% owner

YOUNG PHILIP M · CIK 0001048637 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by USVP IX

Disclosed balance after: 8,000,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · kind: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F1 · price: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3 · ownership.nature: The shares are held of record by U.S. Venture Partners IX, L.P. ("USVP IX"). Presidio Management Group IX, LLC ("PMG IX") is the general partner of USVP IX and may be deemed to have sole voting and dispositive power over the shares held by USVP IX. Steven M. Krausz, a director of the Issuer, and each of Irwin Federman, David E. Liddle, Paul A Matteucci, Jonathan D. Root, Casey M. Tansey, and Philip M. Young, are managing members of PMG IX, and may be deemed to share voting and dispositive power over the shares held by USVP IX. Such persons and entities disclaim beneficial ownership of shares held by USVP IX, except to the extent of any proportionate pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.